Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ -population-based follow-up of two cluster-randomized trials.

Autor: Lehtinen M; Department of CLINTEC, Karolinska Institute, Stockholm, Sweden.; Faculty of Medicine, Tampere University, Tampere, Finland., Gray P; Department of CLINTEC, Karolinska Institute, Stockholm, Sweden., Luostarinen T; Institute for Epidemiological Cancer Research, Finnish Cancer Registry, Helsinki, Finland., Eriksson T; Faculty of Medicine, Tampere University, Tampere, Finland., Apter D; Youth Clinic, VL-Medi, Helsinki, Finland., Bly A; Faculty of Medicine, Tampere University, Tampere, Finland., Harjula K; Faculty of Medicine, Tampere University, Tampere, Finland., Heikkilä K; Faculty of Medicine, Tampere University, Tampere, Finland., Hokkanen M; Faculty of Medicine, Tampere University, Tampere, Finland., Kuortti M; Faculty of Medicine, Tampere University, Tampere, Finland., Nieminen P; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland., Nummela M; Faculty of Medicine, Tampere University, Tampere, Finland., Paavonen J; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland., Palmroth J; Department of Obstetrics and Gynecology, University of East-Finland, Kuopio, Finland., Petäjä T; Faculty of Medicine, Tampere University, Tampere, Finland., Pimenoff VN; Department of CLINTEC, Karolinska Institute, Stockholm, Sweden., Pukkala E; Institute for Epidemiological Cancer Research, Finnish Cancer Registry, Helsinki, Finland., Dillner J; Department of CLINTEC, Karolinska Institute, Stockholm, Sweden.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Sep 09; Vol. 14, pp. 1437704. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Autor: Lehtinen M; Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden., Luostarinen T; Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden., Vänskä S; Helsinki and Oulu, Institute for Health and Welfare, Helsinki, Finland., Söderlund-Strand A; Department of Clinical Microbiology, Skåne University hospital, Lund, Sweden., Eriksson T; School of Health Sciences, University of Tampere, Tampere, Finland., Natunen K; School of Health Sciences, University of Tampere, Tampere, Finland., Apter D; VL Medi, Helsinki, Finland., Baussano I; Department of Infections and Cancer, International Agency for Research on Cancer, Lyon, France., Harjula K; School of Health Sciences, University of Tampere, Tampere, Finland., Hokkanen M; School of Health Sciences, University of Tampere, Tampere, Finland., Kuortti M; School of Health Sciences, University of Tampere, Tampere, Finland., Palmroth J; School of Health Sciences, University of Tampere, Tampere, Finland., Petäjä T; School of Health Sciences, University of Tampere, Tampere, Finland., Pukkala E; School of Health Sciences, University of Tampere, Tampere, Finland., Rekonen S; School of Health Sciences, University of Tampere, Tampere, Finland., Siitari-Mattila M; School of Health Sciences, University of Tampere, Tampere, Finland., Surcel HM; Department of Clinical Microbiology, Skåne University hospital, Lund, Sweden., Tuomivaara L; School of Health Sciences, University of Tampere, Tampere, Finland., Paavonen J; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland., Nieminen P; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland., Dillner J; Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden., Dubin G; Takeda Pharmaceuticals International, Zurich, Switzerland., Garnett G; Gates Foundation, Seattle, Washington.

Publikováno v: International journal of cancer [Int J Cancer] 2018 Nov 01; Vol. 143 (9), pp. 2299-2310. Date of Electronic Publication: 2018 Aug 10.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials .

Autor: Lehtinen M; University of Tampere, Tampere, Finland.; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Lagheden C; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Luostarinen T; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Eriksson T; University of Tampere, Tampere, Finland., Apter D; VL-Medi, Helsinki, Finland., Harjula K; University of Tampere, Tampere, Finland., Kuortti M; University of Tampere, Tampere, Finland., Natunen K; University of Tampere, Tampere, Finland., Palmroth J; University of Tampere, Tampere, Finland., Petäjä T; University of Tampere, Tampere, Finland., Pukkala E; Finnish Cancer Registry, Helsinki, Finland., Siitari-Mattila M; University of Tampere, Tampere, Finland., Struyf F; GSK Biologicals, Wavre, Belgium., Nieminen P; University of Helsinki, Helsinki, Finland., Paavonen J; University of Helsinki, Helsinki, Finland., Dubin G; Takeda Pharmaceuticals International, Zurich, Switzerland., Dillner J; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

Publikováno v: BMJ open [BMJ Open] 2017 Aug 18; Vol. 7 (8), pp. e015867. Date of Electronic Publication: 2017 Aug 18.

Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.

Autor: Murahwa, Alltalents T.^1,2 (AUTHOR) alltalents.murahwa@uct.ac.za, Mudzviti, Tinashe^3,4 (AUTHOR) takudzwac@newlandsclinic.org.zw, Mandishora, Racheal S. Dube^5,6 (AUTHOR) racheal.mandishora@moffitt.org, Chatindo, Takudzwa³ (AUTHOR) peacec@newlandsclinic.org.zw, Chanetsa, Peace³ (AUTHOR) margaretp@newlandsclinic.org.zw, Pascoe, Margaret³ (AUTHOR) tineis@newlandsclinic.org.zw, Shamu, Tinei^3,7,8 (AUTHOR) ruedi.luethy@rl-foundation.ch, Basera, Wisdom⁹ (AUTHOR) wisdom.basera@mrc.ac.za, Luethy, Ruedi³ (AUTHOR), Williamson, Anna-Lise^1,10 (AUTHOR)

Publikováno v: Viruses (1999-4915). Jan2024, Vol. 16 Issue 1, p162. 12p.

Need for Sexual, Reproductive, and Mental Health Promotion Among Diverse College Students in a COVID-19 Era.

Autor: Cooley-Strickland, Michele^1,2 (AUTHOR) mcooley@mednet.ucla.edu, Wyatt, Gail E.¹ (AUTHOR), Loeb, Tamra Burns¹ (AUTHOR), Nicholas, Lisa A.³ (AUTHOR), Smith-Clapham, Amber¹ (AUTHOR), Hamman, Amina¹ (AUTHOR), Abraham, Misha⁴ (AUTHOR), Scott, Enricka Norwood¹ (AUTHOR), Albarran, Graciela¹ (AUTHOR)

Publikováno v: Clinical Child & Family Psychology Review. Dec2023, Vol. 26 Issue 4, p1077-1096. 20p.